Fagron NV
Fagron NV FAGR.BR Peers
See (FAGR.BR) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| FAGR.BR | $21.25 | +0.24% | 1.55B | 19.32 | $1.10 | +1.41% |
| IPN.PA | $102.50 | -1.82% | 8.48B | 24.00 | $4.27 | +1.17% |
| VETO.PA | $72.80 | -0.14% | 859.00M | 14.62 | $4.98 | +1.17% |
| BOI.PA | $24.60 | -1.60% | 427.11M | 37.85 | $0.65 | +5.49% |
| MLC.IR | $8.20 | N/A | 170.74M | -205.00 | -$0.04 | N/A |
| AB.PA | $1.48 | +0.96% | 85.36M | -21.09 | -$0.07 | N/A |
| MITRA.BR | $0.22 | N/A | 14.45M | -0.15 | -$1.41 | N/A |
| ALRPD.PA | $0.01 | +1.79% | 825957.00 | -0.29 | -$0.02 | N/A |
| MLGML.PA | $0.04 | -20.00% | 536272.00 | -0.80 | -$0.05 | N/A |
Stock Comparison
FAGR.BR vs IPN.PA Comparison
FAGR.BR plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, FAGR.BR stands at 1.55B. In comparison, IPN.PA has a market cap of 8.48B. Regarding current trading prices, FAGR.BR is priced at $21.25, while IPN.PA trades at $102.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
FAGR.BR currently has a P/E ratio of 19.32, whereas IPN.PA's P/E ratio is 24.00. In terms of profitability, FAGR.BR's ROE is +0.17%, compared to IPN.PA's ROE of +0.08%. Regarding short-term risk, FAGR.BR is less volatile compared to IPN.PA. This indicates potentially lower risk in terms of short-term price fluctuations for FAGR.BR.